Injectable MS drug, peginterferon beta-1a, cut relapse rate

[MSUK]

Injectable MS drug, peginterferon beta-1a, cut relapse rate by 36 percent

Biogen Idec Inc said its experimental multiple sclerosis drug peginterferon beta-1a reduced the annual relapse rate of patients with multiple sclerosis by 36 percent when dosed once every two weeks.

The company, which presented its results at the American Academy of Neurology's annual meeting, said the drug reduced the proportion of patients who relapsed by 39 percent compared with patients who took a placebo....... Read More - http://www.ms-uk.org/index.cfm/PEGylatedinterferonbeta